Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
LSL Pharma Group Inc ( (TSE:LSL) ) has shared an update.
LSL Pharma Group Inc. has completed the acquisition of Laboratoire Du-Var Inc., a contract manufacturer of cosmetics and natural health products. This acquisition will more than double LSL Pharma’s production capacity for liquid and semi-solid products and expand its customer base in the CMO segment, allowing access to new markets in natural health products, cosmetics, personal care, and pet care. The transaction is expected to significantly enhance LSL Pharma’s industry positioning by integrating Du-Var’s expertise and facilities, which will contribute to the company’s strategic plan of building a comprehensive manufacturing hub in Canada.
More about LSL Pharma Group Inc
LSL Pharma Group Inc. is a Canadian integrated pharmaceutical company specializing in the development, manufacturing, and commercialization of high-quality sterile ophthalmic pharmaceutical products, as well as pharmaceutical, cosmetic, and natural health products in solid, semi-solid, and liquid dosage forms.
Average Trading Volume: 54,298
Technical Sentiment Signal: Strong Sell
Current Market Cap: C$40.44M
Learn more about LSL stock on TipRanks’ Stock Analysis page.